Stereochemistry and deuterium isotope effects associated with the cyclization-rearrangements catalyzed by tobacco epiaristolochene and hyoscyamus premnaspirodiene synthases, and the chimeric CH4 hybrid cyclase.
Journal: 2006/June - Archives of Biochemistry and Biophysics
ISSN: 0003-9861
Abstract:
Tobacco epiaristolochene and hyoscyamus premnaspirodiene synthases (TEAS and HPS) catalyze the cyclizations and rearrangements of (E,E)-farnesyl diphosphate (FPP) to the corresponding bicyclic sesquiterpene hydrocarbons. The complex mechanism proceeds through a tightly bound (R)-germacrene A intermediate and involves partitioning of a common eudesm-5-yl carbocation either by angular methyl migration, or by C-9 methylene rearrangement, to form the respective eremophilane and spirovetivane structures. In this work, the stereochemistry and timing of the proton addition and elimination steps in the mechanism were investigated by synthesis of substrates bearing deuterium labels in one or both terminal methyl groups, and in the pro-S and pro-R methylene hydrogens at C-8. Incubations of the labeled FPPs with recombinant TEAS and HPS, and with the chimeric CH4 hybrid cyclase having catalytic activities of both TEAS and HPS, and of unlabeled FPP in D2O, together with gas chromatography-mass spectrometry (GC-MS) and/or NMR analyses of the labeled products gave the following results: (1) stereospecific CH3->>CH2 eliminations at the cis-terminal methyl in all cases; (2) similar primary kinetic isotope effects (KIE) of 4.25-4.64 for the CH3->>CH2 eliminations; (3) a significant intermolecular KIE (1.33+/-0.03) in competitive cyclizations of unlabeled FPP and FPP-d6 to premnaspirodiene by HPS; (4) stereoselective incorporation of label from D2O into the 1beta position of epiaristolochene; (5) stereoselective eliminations of the 1beta and 9beta protons in formation of epiaristolochene and its delta(1(10)) isomer epieremophilene by TEAS and CH4; and (6) predominant loss of the 1alpha proton in forming the cyclohexene double bond of premnaspirodiene by HPS and CH4. The results are explained by consideration of the conformations of individual intermediates, and by imposing the requirement of stereoelectronically favorable proton additions and eliminations.
Relations:
Content
Citations
(6)
References
(16)
Chemicals
(4)
Organisms
(2)
Processes
(2)
Similar articles
Articles by the same authors
Discussion board
Arch Biochem Biophys 448(1-2): 31-44

Stereochemistry and deuterium isotope effects associated with the cyclization-rearrangements catalyzed by tobacco epiaristolochene and hyoscyamus premnaspirodiene synthases, and the chimeric CH<sub>4</sub> hybrid cyclase

Department of Chemistry, University of Illinois, 600 South Mathews Ave., Urbana, IL 61801, USA
Howard Hughes Medical Institute, Jack H. Skirball Center for Chemical Biology and Proteomics, Salk Institute for Biological Studies, 10010 North Torrey Pines Rd., La Jolla, CA 92037, USA
Department of Plant and Soil Sciences, University of Kentucky, Lexington, KY 40546-0091, USA
Corresponding author: Fax: +1 217 244 8024. ude.cuiu.scs@setaoc (R.M. Coates)
Present address: Department of Drug Metabolism, Merck Research Laboratories, RY80R-104, P.O. Box 2000, Rahway, NJ 07065, USA.
Present address: Monsanto Company, 800 N. Lindbergh Blvd., Creve Coeur, MO 63167, USA.

Abstract

Tobacco epiaristolochene and hyoscyamus premnaspirodiene synthases (TEAS and HPS) catalyze the cyclizations and rearrangements of (E,E)-farnesyl diphosphate (FPP) to the corresponding bicyclic sesquiterpene hydrocarbons. The complex mechanism proceeds through a tightly bound (R)-germacrene A intermediate and involves partitioning of a common eudesm-5-yl carbocation either by angular methyl migration, or by C-9 methylene rearrangement, to form the respective eremophilane and spirovetivane structures. In this work, the stereochemistry and timing of the proton addition and elimination steps in the mechanism were investigated by synthesis of substrates bearing deuterium labels in one or both terminal methyl groups, and in the pro-S and pro-R methylene hydrogens at C-8. Incubations of the labeled FPPs with recombinant TEAS and HPS, and with the chimeric CH4 hybrid cyclase having catalytic activities of both TEAS and HPS, and of unlabeled FPP in D2O, together with gas chromatography–mass spectrometry (GC–MS) and/or NMR analyses of the labeled products gave the following results: (1) stereospecific CH3 → CH2 eliminations at the cis-terminal methyl in all cases; (2) similar primary kinetic isotope effects (KIE) of 4.25–4.64 for the CH3 → CH2 eliminations; (3) a significant intermolecular KIE (1.33 ± 0.03) in competitive cyclizations of unlabeled FPP and FPP-d6 to premnaspirodiene by HPS; (4) stereoselective incorporation of label from D2O into the 1β position of epiaristolochene; (5) stereoselective eliminations of the 1β and 9β protons in formation of epiaristolochene and its Δ isomer epieremophilene by TEAS and CH4; and (6) predominant loss of the 1α proton in forming the cyclohexene double bond of premnaspirodiene by HPS and CH4. The results are explained by consideration of the conformations of individual intermediates, and by imposing the requirement of stereoelectronically favorable proton additions and eliminations.

Keywords: Sesquiterpenes, Eremophilanes, Spirovetivane, Germacrane, Enzyme mechanisms, Stereochemistry, Deuterium labeling, Isotope effects, Rearrangements, Cyclizations, Carbocations
Abstract

Tobacco epiaristolochene and hyoscyamus premnaspirodiene synthases (TEAS3 and HPS) [1,2] are terpene cyclases responsible for the production of the respective sesquiterpene hydrocarbons (2 and 5) in the biosynthesis of the oxygenated phytoalexins capsidiol (4), solavetivone (6), lubimin (7), rishitin (8), and related metabolites in sweet pepper, tobacco, potato, and other Solanaceae (Scheme 1) [35].

An external file that holds a picture, illustration, etc.
Object name is nihms195142f3.jpg

Biosynthesis of the sesquiterpene phytoalexins capsidiol (4), solavetivone (6), lubimin (7), and rishitin (8) from (E,E)-farnesyl diphosphate (1) by way of epiaristolochene (2) and premnaspirodiene (5).

Incorporation of [1,2-C2]acetate into capsidiol in Capsicum annum cultures and NMR analyses confirmed the occurrence of a methyl migration in the biosynthesis of this eremophilane sesquiterpene [6]. Retention of deuterium at C4 of capsidiol biosynthesized from [4,4-H2]mevalonate demonstrated that the unusual trans-stereochemistry of the vicinal methyl groups could not be attributed to epimerization of a cis-eremophilane precursor [7].

The hydrocarbon intermediate isolated from elicitor-treated cell cultures of Nicotiana tobacum [8] was identified as (+)-epiaristolochene (2) by comparison with the diene prepared chemically by deoxygenation of capsidiol [9], the structure and stereochemistry of which were established by an X-ray crystallo-graphic analysis [10]. Kinetic analysis of the oxidation of 2 to capsidiol and the potential intermediates epiaristolochen-1β- and -3α-ol with the cytochrome P450 oxidase epiaristolochene dihydroxylase (EAH) established the preferred order of the oxidation steps, 234 [11,12]. The sequence of oxidative transformations and intermediates in the conversion of solavetivone to lubimin and rishitin was elucidated by incorporation of deuterium and carbon-13 labeled precursors [1315]. The presumed sesquiterpene precursor (−)-premnaspirodiene (5) [16] has been synthesized as the pure enantiomer [17] and in racemic form [18], and its identification as the product of HPS rests primarily on GC–MS evidence [19].

The usual mechanism for the closely related processes catalyzed by TEAS and HPS are presented in Scheme 2 [1,2]. Intramolecular alkylation of the terminal double bond of the FPP substrate generates the enzyme bound gremacrene A intermediate (9). Proton-induced cyclization of 9 in a boat-chair conformation leads to a 5,10-syn eudesmyl ion 10A that undergoes 5 → 4 hydride shift to form the branch point intermediate 10B. 1,2-Methyl migration followed by proton elimination give rise to epiaristolochene (2) and epieremophilene (13), whereas ring contraction by C-9 methylene rearrangement and elimination produces premnaspirodiene (5).

An external file that holds a picture, illustration, etc.
Object name is nihms195142f4.jpg

Proposed mechanisms for the cyclizations of (E,E)-farnesyl diphosphate (1) to epiaristolochene (2), epieremophilene (13), and premnaspirodiene (5) catalyzed by the respective synthases TEAS, HPS, and the CH4 hybrid. The reactions proceed through germacrene A (9), and isomeric eudesmyl (10A and 10B), epi-eremophilenyl (11), and vetispirenyl (12) carbocation intermediates. In the case of TEAS, angular methyl migration is favored along the upper branch to the fused ring product whereas in the case of HPS ring methylene rearrangement on the opposite face and proton elimination at C1 lead to the spiro[5.4]decane product. The CH4 mutant form affords a mixture of both products, together with the double bond isomer epieremophilene (13).

The cloning and over-expression of recombinant TEAS and HPS in Escherichia coli provided sufficient quantities of these interesting cyclases for structural and mechanistic investigations [20]. These two proteins are 77% identical and 81% similar based on amino acid sequence alignment, contain the familiar DDXXD aspartate triad linked to diphosphate binding, and have kinetic characteristics typical of terpene cyclases. One of a series of chimeric proteins resulting from domain swapping designated CH4 catalyzed the conversion of 1 to epiaristolochene, premnaspirodiene, and an unknown product subsequently identified as epieremophilene (13), i.e., the Δ isomer of 2 [11,21]. Pre-steady state kinetic data are consistent with either a rate-determining cyclization to the germacrene A intermediate or final dissociation of the bicyclic products, and the existence of a single catalytic site on the CH4 hybrid enzyme [22]. X-ray diffraction analysis of crystalline TEAS in the absence and presence of inert substrate mimics revealed a hydrophobic, aromatic-rich binding pocket in the C-terminal domain with twoMg ions positioned near the opening [23]. The production of germacrene A (9) by the point mutant TEAS-Y520-F confirmed the identity of the macrocyclic intermediate and a role for tyrosine 520 in catalysis, perhaps in contributing to an H-bonding network making up the back of the active site pocket [24].

The functionally similar aristolochene synthases isolated from the fungi Aspergillus terreus and Penicillum roquaforti catalyze the conversion of FPP to the 4β-CH3, 7α-isopropenyl diastereomer of 2 [1,2]. However, the amino acid sequences of these fungal cyclases differ appreciably from those of TEAS and HPS. Labeling experiments established that the macrocyclization step occurs with inversion at C-1 of the substrate and proton elimination at the cis-terminal methyl position, and that conversion of the enzyme-bound intermediate to aristolochene takes place with 10 → 5 methyl migration and syn-related proton elimination [25,26]. Indirect evidence supporting the same germacrene A intermediate (9) was obtained by enzyme-catalyzed cyclization of (7R)-6,7-dihydro FPP to 6,7-dihydro germacrene A [27].

The objectives of the present work were to analyze the timing of the cyclization steps and the stereochemistry of the individual protonation and deprotonation events in the mechanism by means of deuterium labeling. In this paper, we report syntheses of farnesyl PPs bearing deuterium in the terminal methyl groups and in the pro-R and pro-S positions at C-8. The stereochemistry of proton transfer steps was elucidated by GC–MS and/or NMR analyses of the products from incubations of the labeled substrates with the three enzymes and from incubations conducted in D2O. Comparisons of the isotope effects and stereospecificities of the different reactions catalyzed by TEAS, HPS, and CH4 afford new insights on the positions of active site acids and bases, on the determinants of product specificity, and on the rate determining steps.

Footnotes

Abbreviations used: SCS, School of Chemical Sciences at the UI; THF, tetrahydrofuran; DMSO, dimethyl-sulfoxide; DMF, N,N-dimethylformamide; TLC, thin-layer chromatography; NMR, nuclear magnetic resonance; NOE, nuclear Overhauser effect; Hz, Hertz; GC, gas chromatography; MS, mass spectrum; FAB, fast atom bombardment; m/z, mass/charge ratio; PP, diphosphate; FPP, farnesyl diphosphate; pyr., pyridine; 18-C-6, 18-crown-6 ether; Bn, benzyl; Ms, methanesulfonyl; Me, methyl; Et, ethyl; Ph, phenyl; NMO, N-methylmorpholine N-oxide; TEAS, tobacco epiaristolochene synthase; HPS, hyoscyamus premnaspirodiene synthase; CH4, chimeric cyclase construct; KIE, kinetic isotope effect; satd, saturated.

Footnotes

References

  • 1. Cane DE In: Comprehensive Natural Products Chemistry. Barton D, Nakanishi K, Meth-Cohn O, Cane DE, editors. Vol. 2. Elsevier; Amsterdam: 1999. Chap. 6. [PubMed][Google Scholar]
  • 2. Cane DE. Chem Rev. 1990;90:1089–1103.[PubMed]
  • 3. Brooks CJW, Watson DG. Nat Prod Rep. 1985;2:427–460.[PubMed]
  • 4. Brooks CJW, Watson DG. Nat Prod Rep. 1991;8:367–390.[PubMed]
  • 5. Sharma RP, Salunkhe DK Mycotoxins and Phytoalexins. CRC Press; Boca Raton: 1991. [PubMed][Google Scholar]
  • 6. Baker FC, Brooks CJW. Phytochemistry. 1976;15:689–694.[PubMed]
  • 7. Hoyano Y, Stoessel A, Stothers JB. Can J Chem. 1980;58:1894–1896.[PubMed]
  • 8. Whitehead IM, Threlfall DR, Ewing DF. Phytochemistry. 1989;28:775–779.[PubMed]
  • 9. Whitehead IM, Ewing DF, Threlfall DR, Cane DE, Prabhakaran PC. Phytochemistry. 1990;29:479–482.[PubMed]
  • 10. Birnbaum GI, Stoessl A, Grover SH, Stothers JB. Can J Chem. 1974;52:993–1005.[PubMed]
  • 11. Zhao Y, Schenk DJ, Takahashi S, Chappell J, Coates RM. J Org Chem. 2004;69:7428–7435.[PubMed]
  • 12. Takahashi S, Zhao Y, O’Maille PE, Greenhagen BT, Noel JP, Coates RM, Chappell J. J Biol Chem. 2005;280:3686–3696.
  • 13. Murai A, Yoshizawa Y, Katsui N, Sato S, Masamune T. Chem Lett. 1986:771–772.[PubMed]
  • 14. Murai A, Sato S, Osada A, Katsui N, Masamune T. J Chem Soc Chem Commun. 1982:32–33.[PubMed]
  • 15. Whitehead IM, Atkinson AL, Threlfall DR. Planta. 1990;182:81–88.[PubMed]
  • 16. Rao CB, Raju GVS, Krishna PG. Ind J Chem Sect B. 1982;21B:267–268.[PubMed]
  • 17. Hwu JR, Wetzel JM. J Org Chem. 1992;57:922–928.[PubMed]
  • 18. Zee SH, Chou SY, Chinese J. Chem Soc (Taipei, Taiwan) 1990;37:191–195.[PubMed]
  • 19. Back K, Chappell J. J Biol Chem. 1995;270:7375–7381.[PubMed]
  • 20. Back K, Yin S, Chappell J. Arch Biochem Biophys. 1994;315:527–532.[PubMed]
  • 21. Back K, Chappell J. Proc Natl Acad Sci USA. 1996;93:6841–6845.
  • 22. Mathis JR, Back K, Starks C, Noel J, Poulter CD, Chappell J. Biochemistry. 1997;36:8340–8348.[PubMed]
  • 23. Starks CM, Back K, Chappell J, Noel JP. Science. 1997;277:1815–1820.[PubMed]
  • 24. Rising KA, Starks CM, Noel JP, Chappell J. J Am Chem Soc. 2000;122:1861–1866.[PubMed]
  • 25. Cane DE, Prabhakaran PC, Oliver JS, McIlwaine DB. J Am Chem Soc. 1990;112:3209–3210.[PubMed]
  • 26. Cane DE, Prabhakaran PC, Salaski EJ, Harrison PHM, Noguchi H, Rawlings BJ. J Am Chem Soc. 1989;111:8914–8916.[PubMed]
  • 27. Cane DE, Tsantrizos YS. J Am Chem Soc. 1996;118:10037–10040.[PubMed]
  • 28. Still CW, Kahn M, Mitra A. J Org Chem. 1978;43:2923–2925.[PubMed]
  • 29. Morimoto Y, Matsuda F, Shirahama H. Tetrahedron. 1996;52:10609–10630.[PubMed]
  • 30. Yee NKN, Coates RM. J Org Chem. 1992;57:4598–4608.[PubMed]
  • 31. Ravn MM, Jin AQ, Coates RM. Eur J Org Chem. 2000:1401–1410.[PubMed]
  • 32. Jin Q, Williams DC, Hezari M, Croteau R, Coates RM. J Org Chem. 2005;70 ASAP. [[PubMed]
  • 33. Clarke HT, Hartman WW. Org Synth Coll. 1993;1:233–234.[PubMed]
  • 34. Still WC, Gennari C. Tetrahedron Lett. 1983;24:4405–4408.[PubMed]
  • 35. Coates RM, Ley DA, Cavender PL. J Org Chem. 1978;43:4915–4922.[PubMed]
  • 36. Welch SC, Walters MEJ. J Org Chem. 1978;43:4797–4799.[PubMed]
  • 37. Schenk DJ PhD Dissertation. University of Illinois; Urbana, IL: 2000. Diss. Abstr. B; Order No. DA 9990130, 61(2000) 5334. [PubMed][Google Scholar]
  • 38. Corey EJ, Cane DE, Libit LJ. J Am Chem Soc. 1971;93:7016–7021.[PubMed]
  • 39. Corey EJ, Achiwa KJ. Org Chem. 1969;34:3667–3668.[PubMed]
  • 40. Davisson VJ, Woodside AB, Neal TR, Stremler KE, Muehlbacker M, Poulter CD. J Org Chem. 1986;51:4768–4779.[PubMed]
  • 41. Gerlach H, Zagalak BJ. J Chem Soc Chem Commun. 1973:274–275.[PubMed]
  • 42. Gerlach H, Kappes D, Boeckman RK, Jr, Maw GN. Org Synth Coll. 1998;9:151–154.[PubMed]
  • 43. Crandall JK, Pradat C. J Org Chem. 1985;50:1327–1329.[PubMed]
  • 44. Collington EW, Meyers AI. J Org Chem. 1971;36:3044–3045.[PubMed]
  • 45. Woodside AB, Huang Z, Poulter CD. Org Synth Coll. 1993;8:616–620.[PubMed]
  • 46. Schowen KB, Schowen RL. Methods Enzymol. 1982;87:551–606.[PubMed]
  • 47. Ravn MM PhD Thesis. University of Illinois; Urbana, IL: 2000. [PubMed][Google Scholar]
  • 48. Cane DE, Oliver JS, Harrison PHM, Abell C, Hubbard BR, Kane CT, Lattman R. J Am Chem Soc. 1990;112:4513–4524.[PubMed]
  • 49. Ravn MM, Coates RM, Jetter R, Croteau RB. J Chem Soc Chem Commun. 1998:21–22.[PubMed]
  • 50. Lin X, Hezari M, Koepp AE, Floss HG, Croteau R. Biochemistry. 1996;35:2968–2977.[PubMed]
  • 51. Williams DC, Carroll B, Jin Q, Rithner C, Lenger SR, Floss HG, Coates RM, Williams RM, Croteau R. Chem Biol. 2000;7:969–977.[PubMed]
  • 52. Pyun HJ, Coates RM, Wagschal KC, McGeady P, Croteau RB. J Org Chem. 1993;58:3998–4009.[PubMed]
  • 53. Suga T, Hiraga Y, Mie A, Izumi S. J Chem Soc Chem Commun. 1992:1556–1558.[PubMed]
  • 54. Leopold MF, Epstein WW, Grant DM. J Am Chem Soc. 1988;110:616–617.[PubMed]
  • 55. Birnbaum GI, Huber CP, Post ML, Stothers JB, Robinson JR, Stoessel A, Ward EWB. J Chem Soc Chem Commun. 1976:330–331.[PubMed]
  • 56. Botta L PhD Thesis. ETH; Zurich, Switzerland: 1968. [PubMed][Google Scholar]
  • 57. Guglielmietta L PhD Thesis. ETH; Zurich, Switzerland: 1962. [PubMed][Google Scholar]
  • 58. Wagschal KC, Pyun HJ, Coates RM, Croteau R. Arch Biochem Biophys. 1994;308:477–487.[PubMed]
  • 59. Streitwieser A., Jr . Solvolytic Displacement Reactions. McGraw-Hill; New York: 1962. pp. 98–102. [PubMed]
  • 60. Shiner VJ., Jr J Am Chem Soc. 1953;75:2925–2929.[PubMed]
  • 61. Walsh C Enzymatic Reaction Mechanisms. Freeman; San Francisco: 1979. pp. 118–123. [PubMed][Google Scholar]
  • 62. Adio AM, Paul C, Tesso H, Kloth P, König WA. Tetrahedron Asymmetr. 2004;15:1631–1635.[PubMed]
  • 63. Rickert KW, Klinman JP. Biochemistry. 1999;38:12218–12228.[PubMed]
  • 64. Adediran SA, Pratt RF. Biochemistry. 1999;38:1469–1477.[PubMed]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.